ALPHA-ERYTHROPOIETIN IN THE TREATMENT AND PREVENTION OF ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Journal Title: Нирки - Year 2014, Vol 1, Issue 7
Abstract
The paper discusses current international recommendations on the diagnosis and treatment of anaemia in chronic kidney disease. Presents a detailed analysis of the alpha-erythropoietin, discussed the advantages and disadvantages of its application in clinical practice.
Authors and Affiliations
Dmytro D. Ivanov
Keywords
Related Articles
- EP ID EP225234
- DOI -
- Views 94
- Downloads 0
Analysis of the factors of survival to renal replacement therapy in patients with chronic kidney disease
Background. The relationship between chronic kidney disease (CKD) and cardiovascular diseases is important and is characterized by the presence of numerous adverse factors compared with patients with cardiovascular disea...
Target Blood Pressure Level in Diabetes Mellitus Type 2: Evaluation of the Scientific Evidence
The review of the scientific evidence on the control of blood pressure (BP) in patients with diabetes mellitus is given. Their analysis suggests that the optimal level of blood pressure to prevent the development of card...
Dysmetabolic Nephropathies in Children
.
Hypertension Canada’s 2017 Guidelines for the Diagnosis, Assessment, Prevention, and Treatment of Pediatric Hypertension
.
Hypoxia — a Leading Factor of Chronic Kidney Disease Progression
Recent data indicate the involvement of hypoxia in the formation of kidney fibrosis and progression of chronic renal disease. One of the main factors in the chain of damage in the tissue oxygen deficiency is a hypoxia-in...